BeOne Medicines (ONC) Prepaid Assets (2015 - 2026)
BeOne Medicines' (ONC) quarterly Prepaid Assets came in at $190.0 million in Q1 2026, up 12.97% year-on-year from $168.2 million in Q1 2025, and down 10.7% on a QoQ basis from $212.8 million in Q4 2025.
BeOne Medicines (ONC) Prepaid Assets (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of Prepaid Assets data on file, last reported at $190.0 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 12.97% year-over-year to $190.0 million in Q1 2026; TTM through Mar 2026 was $190.0 million, a 12.97% increase from a year earlier, with the FY2025 full-year figure at $212.8 million, up 10.28% from the prior year.
- Prepaid Assets for Q1 2026 stood at $190.0 million, down from $212.8 million in the prior quarter.
- Over the last five years, Prepaid Assets for ONC reached as high as $1.4 billion in Q4 2022 and fell as low as $168.2 million in Q1 2025.
- Historically, Prepaid Assets has averaged $296.4 million across 5 years, with a median of $232.6 million in 2025.
- Across the five-year window, Prepaid Assets soared 401.27% in 2022 and sank 80.99% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $1.4 billion in 2022, then sank by 80.99% to $257.5 million in 2023, then declined by 25.07% to $192.9 million in 2024, then advanced by 10.28% to $212.8 million in 2025, then decreased by 10.7% to $190.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $190.0 million in Q1 2026, $212.8 million in Q4 2025, and $232.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190.00 Mn |
| Dec 31, 2025 | 212.75 Mn |
| Sep 30, 2025 | 232.64 Mn |
| Jun 30, 2025 | 280.52 Mn |
| Mar 31, 2025 | 168.18 Mn |
| Dec 31, 2024 | 192.92 Mn |
| Sep 30, 2024 | 209.08 Mn |
| Jun 30, 2024 | 273.66 Mn |
| Mar 31, 2024 | 231.74 Mn |
| Dec 31, 2023 | 257.47 Mn |
| Sep 30, 2023 | 241.66 Mn |
| Jun 30, 2023 | 255.05 Mn |
| Mar 31, 2023 | 264.84 Mn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 199.77 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 266.44 Mn |
| Dec 31, 2021 | 270.17 Mn |
| Sep 30, 2021 | 235.02 Mn |
| Jun 30, 2021 | 225.46 Mn |